Chadler S: Nebulized opioids to treat dyspnea. American Journal of Hospice & Palliative Care. 1999; 16(1): 418-422.
2.
Enck RE: The role of nebulized morphine in managing dyspnea. American Journal of Hospice & Palliative Care. 1999; 16(1): 373-374.
3.
Young IH, Daviskas E, Veena KA: Effect of low dose nebulized morphine on exercise endurance in patients with chronic lung disease. Thorax. 1989; 44: 387-390.
4.
Beauford W, Saylor TT, Stansbury DW, et al.: Effects of nebulized morphine sulphate on the exercise tolerance of the ventilatory limited COPD patient. Chest. 1993; 104: 175-178.
5.
Davis CL, Hodder CA, Love S, et al.: Effect of nebulized morphine and morphine 6-glucuronide on exercise endurance in patients with chronic obstructive airways disease. Thorax. 1994; 49(4): 393.
6.
Masood AR, Reed JW, Thomas SHL: Lack of effect of inhaled morphine on exercise-induced breathlessness in chronic obstructive pulmonary disease. Thorax. 1995; 50: 529-634.
7.
Harris-Eze AO, Snidhar G, Clemens E, et al.:Low-dose nebulized morphine does not improve exercise in interstitial lung disease. American Journal Respiratory Critical Care Medicine. 1995; 152: 1940-1945.
8.
Leung R, Hill P, Burdon J: Effect of inhaled morphine on the development of breathlessness during exercise in patients with chronic lung disease. Thorax. 1996; 51: 596-600.
9.
Davis CL, Penn K, Ahern R, et al.: Single-dose randomized controlled trial of nebulized morphine in patients with cancer related breathlessness. Palliative Medicine. 1996; 10: 64-65.
10.
Noseda A, Carpiaux JP, Markstein C, et al.: Disabling dyspnea in patients with advanced disease: Lack of effect of nebulized morphine. Eur Respir J. 1997; 10: 1079-1083.
